What innovations are enabling a changeover to continuous?

Here, we speak with Matthew Moorcroft, Vice President of Marketing & Intelligence at Cambrex.

We need to produce molecules faster, more economically and with greater control.

The US opioid crisis has claimed the lives of hundreds of thousands. We examine pharma’s role.

Continuous processing, exporting generics and alleviating drug shortages… what’s new for pharma in business?

A new campaign highlights how far businesses have to go to close the gender pay gap – and pharma is no exception.

After a new approval and multi-million dollar deals, are ADCs finally moving to the forefront in the targeted therapy space?

Why are people still being prescribed giant tablets?

Could the pharmaceutical industry do more to prevent waste entering our water supplies?

The EMA has granted conditional marketing approval for Ervebo, the first vaccine to protect against Ebola.